Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PC 111

Next Previous
Search
Drug Profile

PC 111

Alternative Names: PC-111

Latest Information Update: 09 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator PinCell
  • Class Anti-inflammatories; Monoclonal antibodies; Skin disorder therapies
  • Mechanism of Action Fas ligand protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pemphigus
  • New Molecular Entity Yes
  • Available For Licensing Yes - Pemphigus

Highest Development Phases

  • Preclinical Pemphigus; Stevens-Johnson syndrome

Most Recent Events

  • 27 Mar 2025 PC-111 exclusively licensed to subsidiary of Scinai worldwide
  • 25 Jul 2024 Preclinical development is ongoing Italy (Presentation in Pincell website, July 2024)
  • 01 May 2023 Pincell has patent protection for PC 111 in World (Presentation in Pincell website, May 2023)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top